Volume : 11, Issue : 01, January – 2024

Title:

COMPREHENSIVE STUDY OF IN-VITRO QUALITY CONTROL AND PHYSICOCHEMICAL EVALUATION OF SELECTIVE BRANDS OF DICLOFENAC SODIUM.

Authors :

Shakeel Ahmed Siddiqui, Abu Hurera Khan, Owais Ansari, Shahid Qureshi, Aqib Siddiqui, Kaif Mirza, Sohel Shaikh, Arif Mansoori

Abstract :

This study aims to investigate the in-vitro quality control and physicochemical properties of different marketed brands of diclofenac sodium tablet. The research will involve conducting various laboratory tests, including weight variation test, content uniformity test, drug assay, friability test, and the disintegration and dissolution test. Three brands of diclofenac sodium tablets were used in the study, named brand A, brand B & brand C. Quality control (QC) test results for diclofenac sodium tablets shows that brand A, brand B & brand C confirm to the Indian pharmacopeia (IP) standards.
In terms of weight variation, brand A, B & C have an above the mean weight limit variation of 1.288%, 1.222% and 2.538 respectively. The lower mean weight limit variations are 1.377%, 1.052% and 1.522% respectively, which are within the 7.5% standard limits of IP. Friability tests show that brands A, B and C have an average friability of 0.090%, 0.029% and 0.050% mass loss, which are within the1% mass loss limits of IP.
In terms of drug assay, All brands A, B and C fall under the IP parameter of 90%-110%,respectively.The disintegration test shows that brand A, brand B and brand C fall within a 20-minute time interval segment with disintegration time calculated as14min,14.2 min and 15.3 min for brands A,B and C respectively. Brand A, B and C of diclofenac sodium has a drug dissolution percentage of 97.77%, 98.26% and 99.23% respectively within a 45-min sampling time interval.
Keywords: Diclofenac sodium, quality control testing, weight variation, disintegration, friability, dissolution, drug assay by Non aqueous titration and UV spectrophotometry.

Cite This Article:

Please cite this article in press shakeel ahmed siddiqui et al., comprehensive study of in-vitro quality control and physicochemical evaluation of selective brands of diclofenac sodium., indo am. J. P. Sci, 2024; 11 (01).

Number of Downloads : 10

References:

1. The mechanisms of action of NSAIDs in analgesia. Cashman JN. Drugs. 1996;52:13–23.
2. In vitro dissolution study and assay of diclofenac sodium from marketed solid dosage form in Bangladesh. Sultana T, Sohel MD, Kawsar MH, Banoo R. J Bioanal Biomed. 2017;9:118–122.
3. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Todd PA, Sorkin EM. Drugs. 1988;35:244–285.
4. Comparative in-vitro pharmaceutical quality control evaluations of different brands of ibuprofen tablets marketed in Trinidad & Tobago, West Indies. Gupta MM, Gupta M. World J Pharm Pharm Sci. 2016;5:2325–2534.
5. In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations. Su SF, Chou CH, Kung CF, Huang JD. Int J Pharm. 2003; 260:39–46.
6. United States Pharmacopeia 37th edition. 2014:342-351, 1571-72.
7. Comparative pharmaceutical quality control testing of different brands of paracetamol tablets available in Trinidad & Tobago, West Indies. Gupta MM, Gupta M. Int J Pharm Sci Res. 2016;7:36.
8. Optimizing fast dissolving dosage form of diclofenac sodium by rapidly disintegrating agents. Shenoy V, Agrawal S, Pandey S. Indian J Pharm Sci. 2002;65:197–201.
9. High performance liquid chromatographic determination of diclofenac sodium from pharmaceutical preparation. Ramesh TS, Rajan SS,Vinay CN. Drug Dev Ind Pharm. 2008;13:1307–1314.
10. Diclofenac sodium multisource prolonged release tablets—a comparative study on the dissolution profiles. Bertocchi P, Antoniella E, Valvo L, Alimonti S, Memoli A. J Pharm Biomed Anal. 2005;37:679–685.
11. Design, development and evaluation of rosuvastatin calcium and diltiazem hydrochloride bilayer tablet using combination concept of sustained layer with conventional layer. Gupta MM, Pandey S, Chauhan BS, Gupta N. J Pharm Sci. 2014;11:269–284.